The statin wars
- 29 November 2003
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 362 (9398), 1855-1856
- https://doi.org/10.1016/s0140-6736(03)14934-3
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The statin wars: why AstraZeneca must retreatThe Lancet, 2003
- benefit-risk assessment of Rosuvastatin 10 to 40 milligramsThe American Journal of Cardiology, 2003
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)The American Journal of Cardiology, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionPublished by Oxford University Press (OUP) ,1998